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Abstract 
This integrative review provides a comparative view of cognitive behavioral therapy 
(CBT) and pharmacotherapy (PCT) as treatment modalities for adult depression.  The 
foci of this integrative review are to examine research articles on CBT and PCT to 
determine which therapy, monotherapy or combination therapy, provide a higher level of 
therapy for depression.  The metrics utilized are depression symptom remission, response 
to therapy, recovery from depression, and quality of life.  Individual preference and 
response to treatment vary. This makes the reader more aware that specific populations 
may be more receptive to one therapy instead of the other. 
Keywords: Cognitive behavior therapy, pharmacotherapy, and comparative, best 
treatment modality, depression in adults 
 
 
 
 
 
 
 
 
iv 
 
A COMPARATIVE LOOK AT THE DEPRESSION TREATMENT MODALITIES 
OF COGNITIVE BEHAVIOAL THERAPY AND PHARMACOTHERAPY: AN 
INTEGRATIVE REVIEW 
 
 
 
 
 
 
 
 
 
 
 
© 2016 
Teresa Page 
ALL RIGHTS RESERVED 
 
 
v 
 
Acknowledgements 
I want to thank my husband for all the weekends he sacrificed going camping or 
traveling because I had a paper to write or research.  Thank you for your understanding 
and support.  Now we can finally go the places we want to go and do the things we want 
to do without having to worry about internet connections.  I also want to thank my 
mother for being understanding when I do not have time to meet her for lunch, shop or 
just have time to hang out.  Well mom, now we can do some of those fun things.  
Thank you project committee members.  Dr. Sanders, my project chair who 
helped me through each stage of my project and directed me where I needed to be. 
Dr. Kopis thank you for being the authenticity for this project and your dedication to 
helping me succeed.  Thank you Dr. Kay for encouraging me through the tough times and 
your commitment to the time consuming critiquing. 
Thank you to my friends and colleagues Mary Lynn, Dana, Ronnie, Katheryn, 
Trynequa, and Victoria.  We cried together through the rough times and rejoiced together 
in each other’s triumphs.  Last but not least I want to thank the Lord for giving me the 
strength, brain power, and stamina to complete this massive undertaking. 
 
 
 
 
 
vi 
 
List of Tables 
Tables    Page 
1. Inclusion/Exclusion Table  40 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
List of Figures 
 Figures Page 
1. Table of Evidence  63 
2. IRB Email Approval  66 
 
 
 
viii 
 
Table of Contents 
Signature Page……………………………………………………………………………. i 
Title Page…………………………………………………………………………………. ii 
Abstract………………………………………………………………………………….... iii 
Copyright Page…………………………………………………………………………… iv 
Acknowledgements………………………………………………………………………. v 
List of Tables…………………………………………………….………………………. vi 
List of Figures…………………………………………………......……………………… vii 
Table of Contents………………………………………………………………………… viii 
     Introduction…………………………………………………………………………… 1` 
     Supporting Framework………………………………………………………………. 5 
     Problem Statement…………………………………………………………………….. 6 
     Purpose of the Project………………………………………………………………..... 8 
     Research Goals and Objectives……………………………………......……………… 9 
     Methods……………………………………………………………………………… 9 
          Study Design………………………………………………………………………. 9 
          Problem Formulation…………………………….………………………………… 11 
          Data Collection………………………………….…………………………………. 12 
          Data Evaluation…………………….…………...…………………………………. 14 
          Data Analysis…………….…………….………………………………………….. 16 
               Data Reduction…………………………………………………………..…….. 17 
               Data Display……………………………………………………………………. 18 
               Data Comparison……………………………………………………………….. 18 
               Conclusion Drawing ………………………………………………………….... 19 
Presentation……………………………………………………………………………...... 19 
ix 
 
Evaluation Methods…………………………………..…………………………………... 21 
Results…………………………………………………………………………………….. 22 
               Cognitive Behavioral Therapy………………………………………………….. 23 
               No difference…………………………………………………………………… 24 
               Combination ………………...………………………………………………….. 26 
               Pharmacotherapy……………………………………………………………….. 28 
Discussion……………………………………………………………………………….. 30 
References………………………………………………………………………………… 32 
Appendix A: Literature Matrix………………...…………………………………………. 41 
Appendix B: PRISMA Flow Diagram……………………………………………………. 62 
Appendix C: CITI Training……………………………………...……………………...... 67 
 
                
 
1 
 
           Comparative look at the Depression Treatment Modalities of Cognitive  
Behavioral Therapy and Pharmacotherapy 
 
Depression is a major public health concern with a sobering economic impact of 
billions of dollars per year (CDC, 2015).  The increase in incidence continues to climb, 
adding more stress to the national health care budget.  Supported by the research of 
Angstman, Rasmussen, Herman, and Sobolik (2011), the likelihood of a person being the 
victim of depression in a lifetime have a prevalence rate of about 17 percent.  According 
to the National Institute of Mental Health there are an estimated 15.7 million adults, 18 or 
older, who suffer at least one major episode of depression a year (NIMH, 2009).  This 
alarming number of depression diagnoses continues to climb.  Not only is depression a 
mental health concern it also impairs physical function.  Depression, anxiety, and 
substance abuse are often comorbid conditions with a diagnosis of chronic depression. 
These have a high correlation with medical illness, social, and interpersonal relationship 
problems.  Depression often leads to maladaptive cognitive processing which can cause 
decreased job performance exhibited by absenteeism, decreased performance, and poor 
productivity (Angstman et al., 2011).  
Alarming facts on how depression impacts health care economy and patient care 
outcomes fuel the desire for more effective depression therapies.  The treatment 
modalities of pharmacotherapy (PCT) and cognitive behavior therapy (CBT) are the two 
most commonly utilized treatment modalities for adult depression.  The person that feels 
sad, lonely, and hopeless can be offered depression treatment modalities by their primary 
care provider (PCP).  Consistency in medical management and collaborative care has 
shown to decrease long term health care costs.  However, short term costs have shown an 
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increase due to more collaborative integration of PCPs, psychiatrists, and health care 
managers (Angstman, et al., 2011).  The health care arena of today focuses more on 
health wellness and promotion than tertiary treatment.  Research shows that medical 
management of chronic health problems, such as depression, will decrease health care 
costs and improve patient care outcomes (Angstman, et al., 2011; Kilbourne, Williams, 
Bauer, & Arean, 2012; NICE, 2015). 
Depression is one of the most underdiagnosed mental health illness in primary 
care (USPSTF, 2016), and exhibits a distinctive phenomenology, due to the changes in 
neurobiological, physiological, psychological, and social dynamics.  The significance of 
mental health is a principal concern for PCPs and is echoed by the Commission on 
Mental Health.  Gaps in treatment and the importance on mental health are addressed in 
the statement “the implementation gap prevents our nation from reaping the benefit of 
billions of United States tax dollars spent on research and, more important, prolongs the 
suffering of millions of Americans who live with mental disorders” (Kilbourne et al., 
2012, p.1). 
 The World Health Organization (WHO) ranks depression as the fourth leading 
cause of global burden of disease and it is expected to be the second cause of global 
burden of disease by 2020 (Gyani, Pumphrey, Parker, Shafran, & Rose, 2012).  Despite 
attempts at depression treatment strategies, patient inconsistency, and nonadherence to 
treatment impede success.  Successful depression treatment is evidenced by restoration of 
functioning and quality of life, not just symptom management (Lam & Kennedy, 2015). 
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 Depression is a broad spectrum diagnosis and exhibits many behavioral changes. 
The economic burden of the uninsured, and society’s negative association of a 
depression, diagnoses, steer many depressed people away from seeking treatment.  
Depression is marked by changes in mood and declining participation in pleasurable 
activities.  Diagnosis is determined by the gross screening of the following two questions: 
(a) During the past month have you often been bothered by feeling down, depressed, or 
hopeless?  (b) During the past month have you experienced little interest or pleasure in 
doing things? (NICE, 2015).  The National Institute for Health and Care Excellence 
(NICE, 2015) provide algorithms, pathways, and frameworks to increase knowledge and 
guidance, for PCPs, in depression management. 
There are three levels of depression; mild, moderate, and severe.  The majority, 
70 percent, of depression is categorized as mild.  According to NICE in 2007 the 
estimated incidence of depression ranged from three to six percent of the nation’s 
population.  The spectrum of treatment therapy ranged from CBT to hospitalization for 
management of depression.  People requiring treatment for depression are predicted to 
increase by 17 percent, 1.45 million people, by 2026 (NICE, 2015).  Standards of care for 
the depressed population are described by NICE as high quality and cost-effective 
collaborative care that improves the safety and effectiveness of treatment (NICE, 2015). 
Guidelines for depression, provided by NICE, do not specify which treatment 
modality, CBT or PCT, offer the best results for complete remission and restoration of 
functioning and quality of life.  In this integrative review on CBT and PCT, existing 
research studies were analyzed for comparisons in the treatment of symptoms, obtaining 
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remission, and the restoration in quality of life.  Indecision remains, among PCPs, as to 
which is the most effective depression treatment modality, CBT or PCT (Lam & 
Kennedy, 2015; Sinyor, Schaffer & Levitt, 2010).  
Cognitive behavioral therapy and PCT, for the treatment of adult depression, vary 
by many techniques.  The most significant variation is the ability to keep the person in 
remission and maintain functioning and improved quality of life.  The Sequenced 
Treatment Alternative to Relieve Depression Trial (STAR*D) was a large scale trial 
funded by the United States. National Institute of Mental Health (Sinyor et al., 2010).  
This trial examined treatment options for patients refractory to antidepressant therapy.  
This trial had four levels: consisting of (a) monotherapy of an antidepressant medication; 
(b) medication switching to another medication or CBT; (c) medications augmented with 
CBT; and (d) medication changing with other medications.  The trial allowed a 
collaborative decision to be made in determining which treatment option the patient 
received.  The four level trial was designed to mimic real-life situations.  In real-life 
situations the patient is the center of therapy and has a choice in their therapy modality.  
Limitations of this trial was allowing the multiple treatment modalities to impede 
sample size.  This produced groups too small for meaningful and clinical differences 
between treatments (Lam & Kennedy, 2015).  One error in the trial was that CBT was 
never tested alone.  The advantage of CBT was fewer side effects and patients remained 
in remission longer than with PCT (Sinyor et al., 2010).  This trial did bring into question 
if different treatment modalities would work better or more effectively in particular 
patient populations? 
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 Pharmacotherapy was shown to be more effective initially in moderate to severe 
depression.  Pharmacotherapy alone can help with symptom reduction.  However, 
remission and return to a productive, quality life is less likely in the patient with severe, 
multiple depressive episodes (Sinyor et al., 2010).  Combination therapy was recognized 
as effective in some patient populations.  Pharmacotherapy helped the depressive 
symptoms to subside earlier and CBT helped the patient obtain and stay in remission 
which allowed the patient to regain productivity and improved quality of life.  Evaluation 
measurements were obtained with the utilization of the Hamilton Depression Rating 
Scale (HDRS) and the Quick Inventory of Depression Symptomology- Self-Report (Lam 
& Kennedy, 2015).  Measurement-based care provided the tools needed to help evaluate 
and augment the effectiveness of the depression treatment modality being utilize. 
Supporting Framework 
Consumer- centered collaborative care of depression was utilized for patient care 
management.  The primary purpose of this project was to evaluate CBT and PCT for best 
adherence, symptom management, symptom remission and restoration of a quality life.  
The Consumer-Centered Collaborative Care of Depression (McCusker, Yaffe, Sussman, 
Kates, Mulvale, Jayabarathan…….Haggerty, 2012) was the framework that provided 
guidance for the project.  This framework considers the patient to be the center of care 
and focuses on meeting health care needs while collaboratively working with the patient 
and family.   
Morgan & Yoder (2012) considered the defining attributes of the Person-
Centered- Care concept to (a) maintain a holistic approach, (b) individualize care, (c) at 
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all times be respectful, and (d) empower the patient to own and manage self-depression, 
with supporting resources.  The single and most impacting influence of this framework 
was “the philosophy of putting the relationship before the task when planning care” 
(Morgan & Yoder, 2012, p.10).  McCusker et al. (2012) devised and prioritized a list of 
eight attributes that were the most important for a cohesive working arrangement among 
the primary care provider, family and patient.  These attributes, in order, are (1) 
respectfulness; (2) involvement of consumer in treatment decisions; (3) accessibility; (4) 
provision of information; (5) system coordination; (6) whole-person care; (7) 
responsiveness to changing needs; and (8) comprehensiveness. 
Problem Statement 
 Depression is the number one mental health disorder and is often undiagnosed.  
The vast majority of depression is treated in primary care.  Treatment for depression 
requires consistency and a sound evidenced based foundation (Gyani, et al., 2012).  
Statistical data to support the significance of a succinct depression treatment protocol can 
be seen in all age ranges as reported by the Center for Disease Control (CDC, 2015).  The 
Guide to Clinical Preventive Services offer recommendations by the United States 
Preventive Services Task Force (USPSTF, 2016) for primary care settings.  The most 
prominent recommendation, for depression treatment, is to utilize depression screening 
tools in conjunction with preventive services (CDC, 2015).  The United States Preventive 
Services Task Force acknowledges most health care providers are the gatekeepers to 
interventions and recommendations.  
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The United States Preventive Services Task Force and Clinical Guide provide 
three recommendations for all providers.  These recommendations include (a) 
reinforcement of health care provider’s advisement; (b) identify of the most effective 
community-based and health–care programs that will offer education and other 
supportive interventions; and (c) identification of supportive services for the patient 
population (CDC, 2015).  These guidelines should be utilized in the management and 
treatment of one of the top ten chronic diseases, depression.  Cognitive behavioral 
therapy and PCT are listed as the two top depression treatment and management 
modalities.  The phenomenon of uncertainty between these two depression treatment 
modalities needs further evaluation.  
Depression is not limited to any single age and is seen throughout all aspects of 
socioeconomics (CDC, 2015).  The CDC found from 2007 to 2010, in any two week 
period, eight percent of persons, 12 years of age and older, were diagnosed with 
depression (CDC, 2015).  Eight million patients were seen nationwide with the diagnosis 
of depression from 2009-2010.  These patients were seen in hospitals, outpatient clinics, 
physician offices, and emergency rooms.  This number continues to escalate as 
depression remains the number one mental illness.  Major depressive disorders were seen 
as first-line diagnosis in hospital discharges from 2009-2010.  The discharge diagnose of 
depression alone were estimated to be around 395,000 (CDC, 2015).  
 Health care costs continue to escalate while there remains limited mental health 
services to the high risk population (USPSTF, 2016).  The average length of hospital time 
for a major depression episode is six and one half days.  Often the high risk population 
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are uninsured or lack mental health coverage.  This equals lost hospital revenue and 
compounds health care issues (CDC, 2015).  Mental health is crucial to overall health.  
Often outpatient clinics, counseling services, support groups, or primary care services are 
unavailable or unsuccessful with depression management (CDC, 2015).  This only adds 
to an already overwhelmed health care system.  
Purpose of the Project 
The purpose of this integrative review was to review current literature on the 
difference between CBT and PCT treatment modalities of depression in the adult 
population.  Differences that were looked at were symptom management, remission and 
quality of life (QOL).  Follow up care was seen as a vital part, for patient management, 
after referral or during current treatment.  Patients can get lost in the system thus 
impacting quality and continuity of care.  The prudent practitioner maintains close 
follow-up parameters to stay in touch with the patient and monitor treatment progress 
(Zaccagnini, & White, 2014).  Additional resources for continuity of care utilize best 
practice standards, as well as ongoing educational programs and management of chronic 
diseases (NICE, 2015). 
The overall consideration of this integrative review was a systematic evaluation to 
help determine which is more effective, CBT or PCT, in achieving remission and 
improvement in QOL?  The population focused on is the 18 to 65 year old, depressed 
aggregate. The two depression treatment and management modalities focused on were 
CBT and PCT, these are supported by NICE guidelines for depression treatment as the 
most frequently recommended and utilized (Clark, 2011).  
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Research Goals and Objectives 
This integrative review specifically addressed clinical outcomes of the depressed 
adult population as result of treatment with CBT or PCT.  
The goals of this project:  
1. To provide a systematic review of research comparing the depression treatment 
modalities of CBT and PCT 
2. To provide a review of research that will present evidence as to which treatment 
modality, CBT or PCT, help the depressed person reach symptom remission.  
3. To provide a review of research that will present evidence as to which treatment 
modality, CBT or PCT, help the depressed person improve QOL.  
The initial literature review was completed utilizing the support of Harris Copper’s 
(1982) Scientific Guidelines for Conduction Integrative Research Reviews.  This 
conceptual framework allowed for a systematic organized manner to process data.  Three 
research strategies where utilized in obtaining specific primary data on CBT and PCT.  
Methods 
Study Design 
 The underpinning of literature reduction was obtained by categorizing and coding 
by specific criteria.  Types of studies were reduced to meta-analysis, meta-analysis and 
systematic reviews of randomized controlled trials, clinical guidelines based on 
systematic reviews, randomized controlled trials, and non-randomized control trial  Prior 
to this step particular topics were reduced to searchable themes.. The phenomena 
reviewed were depression treatment modalities of CBT and PCT which were coded as 
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such.  The literature search was on the population of depressed adults, 18 to 65 years old, 
and restricted any co-morbid conditions.  This was the preliminary criteria for data 
collection.  Whittemore and Knafl’s (2005) rational for data reduction followed this 
statement; “succinct organization of the literature facilitates the ability to systematically 
compare primary sources on specific issues, variable, or sample characteristics” (p. 550). 
Data was extracted from primary sources and displayed in a matrix table (se 
Appendix A for the literature matrix).  This was in alphabetical order according to the 
author’s name.  This process enhanced visualization and maintained an organized chart.  
Patterns and relationship of literature were displayed to assist in carefully analyzing the 
data.  The matrix provided an organized manner to systematically categorize each 
research journal article utilized in this integrative review.  A graph containing all data on 
utilized articles provided a second means of validation (see Figure 1 for the table of 
evidence). 
The data comparison stage further examined and compared the themes, 
categories, similarities, differences, key components and grouping.  A concept map 
revealed the main idea of depression treatment modality and surrounding variables.  The 
data presentation matrix allowed for visualization of accurate and meaningful 
comparisons, relevant theme, similarities, patterns, and differences.   
The depression treatment modalities of CBT and PCT focused on symptom relief, 
remission, and quality of life. Findings became apparent from analyzing 23 research 
studies which treatment modality offered the best patient outcomes.  Trials favoring 
treatment with CBT alone contained one hundred fifty-five trials and had better symptom 
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relief, remission, improved quality of life, and had enduring effects from the therapy.  
One hundred thirty-one trials showed equal patient treatment response with 
pharmacotherapy alone or with CBT alone.  One hundred thirty trials responded more 
favorably to the treatment of combination therapy.  Two trials presented results that 
showed PCT providing better patient outcomes in the depressed adult population without 
depression relapses.  (see Appendix A for the literature matrix). 
Four meta-analysis contained 155 trials revealing data that CBT had a higher 
depression remission rate than combination therapy or PCT alone.  Two random control 
trials represented data confirming CBT to be the superior treatment modality for 
depression.  Combination therapy was supported by three meta-analysis containing 106 
trials that showed remission of depression symptoms, 36 trials addressed quality of life 
(QOL) and one control trial addressed remission and recovery 
Equal treatment outcomes with cognitive behavioral therapy alone or PCT alone. 
was supported by 131 trials.  In these trial there were six meta-analysis that consisted of 
128 trials, 56 trials with data to support remission alone, and 72 trials showing response 
and remission to treatment.  This project revealed two random control trials supporting 
PCT as the superior treatment.  One trial showed response and remission and the other 
trial only addressed remission.  
Problem Formulation 
An integrative review demands rigor and high standards.  To maintain this 
rigorous standard, extensive training was completed with the Collaborative Institutional 
Training Initiative ([CITI], see Appendix C CITI training certificate).  This integrative 
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review was driven by the need to disclose the best treatment modality for the adult 
depressed population.  The mental health population deserves the least invasive, cost 
conscious, effective treatment for depression.  This integrative review utilized the robust 
methodology of Cooper (1998) and Whittemore and Knafl (2005).  Following this 
methodology maintained rigor and decreased bias.  Following procedure, an application 
was presented to the institutional review board (IRB).  There were no human subjects or 
contact with medical records in this paper.  However, for sake of rigor and experience, 
this process was followed.  
Data Collection   
 Data collection and literature review were held to stringent analysis.  This 
procedure helped maintain proper coverage of the phenomena of depression and 
treatment modalities of CBT and PCT Cooper (1982) and Whittemore & Knafl (2005) 
both agree there are two goals for data collection:  (a)“findings that pertain to all previous 
research on the problem, and (b) findings that allow for generalization to the unit of 
analysis that interests the topic area” (Cooper, 1982, p. 294-295).  A comprehensive 
review of literature was performed on the CBT and PCT.  Inclusion and exclusion criteria 
contained the age limit of 18-65, only English full text peer review journal articles, and 
date restriction of 2009-2016 (see Table 1 for the inclusion and exclusion criteria). 
  Data were retrieved from seven databases and multiple data retrieval techniques 
were utilized  A comprehensive search strategy included a computer-assisted search of 
the Cochrane Library, Pub Med, Medline, National Guideline Clearinghouse, Cumulative 
Index of Nursing and Allied Health Literature (CINAHL), Researchgate and Elton B. 
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Stephens Co. host. (EBSCO) Data retrieval was restriction by the inclusion and exclusion 
criteria.  A review of the literature was analyzed for topic specific data.  Key words and 
phrases that were used for search included:  cognitive behavior therapy, 
pharmacotherapy, comparative, best treatment modality, depression, and adults.  
Research articles were obtained and placed in topic specific reservoirs. Further exclusion 
criteria included age, comorbid conditions, and limited to full text articles written in 
English.  The compilation of data was examined and placed in the matrix (see Appendix 
A for the literature matrix).  There were two key areas to consider when assessing 
validity.  
The retrieved studies were obtained and assessed utilizing the inclusion and 
exclusion criteria.  Reviews were examined for differences and similarities.  The 
realization that all the reviews did not contain all pertinent topics of interest were a 
factor in data collection.  To protect validity and minimize biased research, as many 
sources as possible were reviewed.  Acknowledging the possibility of missed or 
overrepresented samples are mentioned as a possible impact on the findings (Cooper, 
1998).  The population of focus was adults with the primary diagnosis of depression and 
without comorbid conditions.  Cognitive behavioral therapy and PCT were looked at 
individually and comparatively, and assessed for management of depression symptoms, 
remission rates and QOL. 
Levels of evidence were established utilizing the valid tool Melnyk Pyramid 
(2011).  Melnyk Pyramid has seven levels of evidence, each one with specific criteria. 
Level one has the highest level and maintains strict adherence to “systematic review and 
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meta-analysis of randomized controlled trials; clinical guidelines based on systematic 
reviews or meta-analysis” (Melnyk & Fineout-Overholt, 2011, p.1).  Melnyk Pyramid 
(2011) provided an algorithm to assist in identifying each level of evidence.  These 
validated levels added rigor and authenticity to this study.  In this integrative review the 
levels of evidence according to Melnyk ranged from level one to level three.  Level one 
had 13 articles, level two had nine articles, and level three had one article    
Data Evaluation 
 Data evaluation is a critical part of relevant research.  Points were assigned to 
specific research data criteria.  Studies were reviewed with these points in mind.  Data 
with too many irrelevant factors were excluded.  Evaluating data for this integrated 
review was complex especially since this process utilized qualitative, quantitative and 
governmental standards as metrics.  The quality of these resources were evaluated for 
authenticity, quality, informal value, and methodology.  The mixed-method methodology 
provided diversity making this integrative review unique with a broad spectrum view to 
assess new approaches to the phenomena of depression treatment (Whittemore & Knafl, 
2005).  
Cooper (1982) and Whittemore & Knafl (2005) models were utilized as the 
conceptual frameworks for format organization of this integrative review.  Cooper’s 
(1982) conceptualized model for an integrative review contained five stages: (a) problem 
formulation; (b) data collection; (c) evaluation of data points; (d) data analysis and 
interpretation; and (e) presentation of results.  Whittemore & Knafl (2005) provided a 
similar format to Cooper (1982).  However, the data analysis stage was more elaborate 
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and further delineated the differences in data reduction, data display, data comparison, 
conclusion drawing and verification.  These additional steps enhanced the rigor of this 
process.  
Instructions to guide an integrative review were provided in an articles by 
Whittemore & Knafl (2005)  An integrative review was defined by Whittemore & Knafl 
(2005) as “a specific review method that summarizes past empirical or theoretical 
literature to provide a more comprehensive understanding of a particular phenomenon or 
health care problem” (p. 546).  An integrative review involves interdisciplinary 
collaboration to bring to light a new paradigm of a phenomena in original research.  The 
systematic rigorous method of research, collection, analysis, and presenting outcomes, 
added to the scholarly standard of the original research (Cooper, 1982; Moran et al., 
2014; Whittemore & Knafl, 2005).  Moran et al. (2014) support the scholarly approach to 
an integrative review as “a serious, discipline work that seeks to interpret, draw together, 
and bring new insight to bare on original research” (p. 64).   
The PRISMA checklist provided established guidelines to follow for evaluation of 
qualitative and quantitative data.  Both, Cooper (1982) and PRISMA defined criteria of 
an integrative review to: 
Identify an appropriate topic or issue for the review, justify why a literature   
review is an appropriate means of addressing the topic or problem, search and 
retrieve the appropriate literature, analyze and critique the literature, and create 
new understanding of the topic through one or more forms of synthesis. (Torraco, 
2005, p. 356-357)   
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These models added rigor and provided guidance throughout this integrative 
review.  The step by step sequencing provided details for data collection and additional 
resources provided guidelines for critiquing (Coughlin & Cronin, 2007; Ryan, 2009).  An 
important step in problem formation was to identify the conceptual and operational 
variables.  PRISMA and Cooper (1982) share an intricate design that was mimicked and 
specific parameters were maintained.  These parameters utilized the five stages of 
structure to provide further rigor.  The PRISMA model added further structure to the 
review. and the step by step instructions of PRIMSA provided the specifications needed 
to ensure the precision of this scholarly prepared project. 
 Variable inclusion and exclusion pertain to the significance of data being too 
narrow or too broad (Whittemore & Knafl, 2005).  This procedure helped define which 
variables were relevant and which were irrelevant.  The significance of the foundational 
work impacted the reviews validity.  “Narrow concepts might make review conclusions 
less definitive and robust.  Superficial operational details might obscure interacting 
variables” (Cooper, 1982, p. 293).  Cooper (1998) stated primary research begins with 
specific well defined parameters and integrative reviews begin with an idea or loose 
comparisons and become well defined as EBP research prevails.  This integrative review 
followed this idea for project formulation. 
Data Analysis 
 The data analysis of this integrative review used specific word codes for inclusion 
and exclusion of literature (see Table 1 for inclusion and exclusion criteria).  Cooper 
(1982) inferred that integrative reviews were not obligated to apply the typical standard 
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analysis, therefore a coding system was introduced to provide rigor to this review.     
Whittemore & Knafl (2005) recommended the use of codes, categories, summarization of 
integrated conclusions about the research.  Research and literature were categorized into 
types of studies for this review.  Inclusion and exclusion tables provided a concrete 
means of evaluating variables.  Methods that were utilized to analyze data for this review 
were supported by Whittemore & Knafl (2005).  “A constant comparison method is one 
overarching approach used in a broad array of qualitative design that converts extracted 
data into systematic categories, facilitating the distinction of patterns, themes, variations, 
and relationships” (Whittemore & Knafl,  2005, p. 530).  This method assisted in the 
synchronization of data for this review.  
Levels of evidence were supported with the utilization of the Melnyk Pyramid 
(2011), which has seven levels of evidence, each one with specific criteria.  Level one 
had the highest level and maintains strict adherence to “systematic review and meta-
analysis of randomized controlled trials; clinical guidelines based on systematic reviews 
or meta-analysis” (2011, p.1).  Melnyk Pyramid (2011) further assisted the reviewer, 
with an algorithm for each level of evidence.  These validated levels added rigor and 
authenticity to this study.  In this review validation ranged from level one the level three, 
eleven level one, and twelve level two, and one level three study. 
   Data reduction.  The underpinning of literature reduction was obtained by 
categorizing and coding specific criteria.  Types of studies were reduced to meta-analysis, 
systematic reviews of randomized controlled trials, clinical guidelines based on 
systematic reviews, randomized controlled trials, and non-randomized control trial.  Prior 
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to this step, particular topics were reduced to searchable themes.  Depression was the 
phenomena reviewed with the treatment modalities of CBT and PCT.  The search criteria 
reduced the number of articles for review to 23.  Additional filtering criteria was 
population of depression to adults 18 to 65 years old and restricted any co-morbid 
conditions.  Whittemore and Knafl’s (2005) rational for data reduction followed this 
statement;  “succinct organization of the literature facilitates the ability to systematically 
compare primary sources on specific issues, variable, or sample characteristics” (p. 550). 
Data display.  Data was extracted from primary sources and displayed in a matrix 
table (see Appendix A for the literature matrix) and displayed in alphabetical order 
according to the author’s last name.  This process enhanced visualization and maintained 
organization.  Patterns and relationship of literature were displayed to assist in carefully 
analyzing data.  The matrix provided an organized manner to systematically categorize 
each research journal article in this integrative review.  A graph containing all the data 
provided a second means of verification (see Figure 1 for the table of evidence). 
Data comparison.  The data comparison stage further examined and compared 
the themes, categories, similarities, differences, and identified key components and 
groups.  A concept map revealed the main idea of depression treatment modality and 
surrounding variables.  The data presentation matrix allowed visualization of accurate 
and meaningful comparison patterns.  These comparisons revealed themes, similarities 
and differences that made this integrative review a valid source of informative on the 
depression treatment modalities of CBT and PCT 
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Conclusion drawing and verification.  Caution was exercised in this area to 
avoid biased conclusions of data analysis.  Whittemore & Knafl (2005) pointed out the 
importance of avoiding premature closing options that can conclude research:  
Explicit care needs to be undertake during this process to avoid premature 
analytic closure (being locked into a particular pattern) or exclusion of pertinent 
evidence.  Addressing conflicting evidence is a considerable challenge, 
particularly when results are equally compelling and from high quality reports. 
(p.551)  
Subgroups were categorized into four groups; CBT alone, PCT alone, combination, and 
no difference in treatment.  Trials were separated by categories of 13 meta-analysis, nine 
randomized control trials, and one control trial.  This integrative review consisted of 
51,068 subjects and 418 trials.  Patient response to CBT, PCT, combination and no 
difference in treatment outcomes were assessed by specific criteria.  The evaluation 
criteria revealed symptom responses in 10 studies, 16 studies with remission, two studies 
with recovery, and three studies revealed the patient QOL was impacted.  The results of 
trial numbers and participation response are as follows:  CBT was represented by 155 
trials, no difference was represented by 131 trials, combination therapy had 130 
supportive trials, and PCT had two supportive trials.  
Presentation 
 This integrated review maintained rigor and an extensive research of the topic. 
Careful attention was devoted to data collection, assessment, and analysis to not omit or 
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embellish data.  The methodology was clear and concise, each step could easily be 
reproduced to capture the same information presented in the original integrative review.   
The PRISMA model provided an evidenced based set of items, in the forms of a flow 
diagram and checklist.  These tools assisted in maintaining rigor and validity.  These 
tools provided transparency to the data collection and display. 
 Tables and flow charts provided fluency in the data presentation and offered 
reproducible methodology.  Presentation of data in this format provided transparency and 
instilled a trustworthy aspect to the review data.  Data presented with as much detail as 
possible, in a format that was easily interpreted, decreased the chances of unintentional 
bias of data (see Appendix A for the literature matrix and Figure 1 for the table of 
evidence). 
 This integrative review allowed unconventional data presentation and therefore, 
afforded the research community the opportunity to fashion additional concepts 
previously not considered.  Utilizing this method may help bridge the gap in areas 
otherwise thought to be closed.  Whittemore and Knafl (2005) and Cooper (1982) gave 
caution to combining dissimilar data due to the complexity of assimilation.  However, 
Whittemore & Knafl (2005) encouraged methodology whereas mixed method literature 
and qualitative research had potential to decrease bias and error.  Maximum effort was 
extended to present unbiased material.  This integrative review contained qualitative as 
well as quantitative research studies.  Levels of evidence utilized Melnyk Pyramid 
(2011), which has seven levels of evidence, each one with specific criteria.  Each journal 
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article was subjected to the rigor of this pyramid and assigned levels of evidence. All the 
articles had high levels of accuracy and validity. 
Evaluation Methods 
This integrative review received on-going evaluation, by the researcher, to 
maintain rigor and a non-biased evaluation of the existing literature on depression 
treatment modalities of CBT and PCT.  The topics of CBT, PCT, depression treatment, 
adult depression, opposition treatment, were searched through specific research data 
bases  These databases were utilized in the literature search for this integrative review:  
computer-assisted search of the Cochrane Library, Pub Med, Medline, National 
Guideline Clearinghouse, Cumulative Index of Nursing and Allied Health Literature 
(CINAHL), Researchgate and Elton B. Stephens Co. (EBSCO) from 2009 to 2016. 
A comprehensive research yielded 76,504 articles and an additional 20 from 
references of other research studies.  Resources were screened for duplicates, and 
inclusion and exclusion criteria.  Research studies remaining that met eligibility criteria 
were 127.  After further evaluation of these articles for comparisons within the age range 
and without comorbidities, the remaining studies left for data collections were 23 peer 
review articles.  These 23 articles were placed in a matrix for transparency and 
organization.  The matrix was alphabetized by the journal author’s name.  Included in the 
matrix was type of study, number of subjects, number of trials, and the metrics of 
response, remission, recovery, and QOL.  Each article was categorized by supporting 
treatment; CBT, PCT, combination, and no difference.  Depression tools utilized for 
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obtaining metrics were the Hamilton Rating Scale for Depression (HRSD) and 
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). 
The final 23articles were further sorted by levels of evidence utilizing the Melnyk 
model.  Once these were sorted, each article was analyzed for research design.  These 
yielded an overall total design of 13 meta-analysis, one control trial, and nine randomized 
control trials.  These 23 articles presented with significantly high levels of evidence.  
Melnyk Pyramid of Levels of Evidence followed strict guidelines for leveling evidence.  
The following three levels were represented in this integrative review: 12 level one, nine 
level two, and one level three study.  The Melnyk Model defined the levels as follows: 
Level one is a systematic review & meta-analysis of randomized controlled trial; clinical 
guidelines based on systematic reviews or meta-analysis, Level two represented one or 
more randomized controlled trials, and level 3 represents controlled trial (non-
randomized), (Melnyk & Fineout-Overfelt, 2011). 
Articles were selected and thoroughly evaluated by the PRISMA model, to meet 
all the specific and limited criteria.  The articles were categorized by supporting topics 
which were CBT, PCT, combination and no difference. The metrics utilized were 
symptom remission, response, recovery, and quality of life.  Included in this review were 
51,068 patients, and 418 trials.  Methods of reliability relied on the reputation and 
validity of the PRISMA model and Melnyk levels of evidence. 
Results 
This integrative review added to the existing body of knowledge on depression 
treatment modalities of CBT and PCT, in the adult population.  The research categories 
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that were utilized for consistent treatment therapy and matrix grouping were CBT alone, 
PCT alone, combination therapy, and, no difference between the therapies.  A thorough 
evaluation of literature is represented in this review  
Cognitive Behavioral Therapy.  Cognitive behavioral therapy proved to be the 
best treatment option found in this integrative review.  Out of the original 23 articles five 
articles found CBT superior to treatment as usual (TAU) which consist of PCT.  One 
hundred fifty-five trials consisting of four meta-analysis and one randomized control trial 
supplied data to support CBT for depression is more effective than PCT (Bockting et al., 
2015; Cuijpers et al., 2014; Cuijpers et al., 2013; Karyotaki et al., 2016; Linde et al., 
2015).  
The 14,958 subjects in these trials showed significant treatment outcomes 
utilizing CBT.  The subjects presented with symptom relief, and showed enduring effects 
with longer periods of time between depression episodes.  Cognitive behavioral therapy 
proved to have lasting effects even if the sessions were only during the acute phase of 
depression.  Individual biological and neurological make-up affect each person’s 
response to treatment.  Therefore, a closer look at personalized therapy development 
which could impact patient cost and depression outcomes (Bockting et al., 2015; 
Cuijpers, et al., 2012; Cuijpers, et al., 2013; Driessen, et al., 2016; Hegerl et al., IsHak et 
al., 2011; 2010; Karyotaki et al., 2016; Quilty et al., 2014; Roshanaei-Moghaddam et al., 
2011; Sinyor et al., 2010; & Weitz et al., 2015).  
Cognitive behavioral therapy offers two benefits not found with PCT.  Research 
showed that increased episodes of depression presents with resistance against the effects 
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of medication or PCT (Bockting et al., 2015).  Therefore, it is not an option to continue to 
increase and change PCT.  However, this is what is often seen in current practice. 
Another factor that impacts patient compliance and response to therapy is attitudes 
toward antidepressant medications.  There are patient populations that prefer 
nonpharmacological options to treat depression (Linde et al., 2015). CBT is a viable, cost 
effective alternative. 
Metrics that were consistent throughout all the studies, to assess depression and 
responses, were DSM-IV and the Hamilton Rating Scale for Depression (HRSD). 
Additional metric tools utilized in some of the studies were Beck Depression Inventory-
Fast Screen (BDI-FS), Dysfunctional Attitude Scale (DAS), Montgomery Asburg 
Depression Rating Scale (MADRS), Trimbo’s/IMTA Self Report Questionnaire for Costs 
Associated with Psychiatric Illness (TIC-P), and Structured Clinical Interview for DMS-
IV, DAS). 
No Difference.  A selective groups of research articles were analyzed to gather 
evidenced based research (EBR) on the most effective depression treatment modality 
between CBT and PCT.  Cognitive behavioral therapy and PCT were the two top 
depression treatment therapies recognized by the National Institute for Health and Care 
Excellence (NICE, 2015).  Selected research was analyzed revealing 131trials that 
showed CBT alone or PCT alone provided the same patient treatment outcomes  
(Cuijpers et al., 2012; Cuijpers et al., 2015; Cuijpers et al., 2013; Cuijpers et al., 2010; 
Gartlehner et al., 2016; Hegerl et al., 2010; Henkel et al., 2010; Roshanaei-Moghaddam 
et al., 2011; Quilty et al., 2014, Weitz et al, 2015). 
25 
 
Cognitive behavioral therapy and PCT have specific individualized 
characteristics. When treating adult depression, therapies needed to be assessed for 
personalized therapy (Bockting et al., 2015; Cuijpers, et al., 2012; Cuijpers, et al., 2013; 
Driessen, et al., 2016; Hegerl et al., IsHak et al., 2011; 2010; Karyotaki et al., 2016; 
Quilty et al., 2014; Roshanaei-Moghaddam et al., 2011; Sinyor et al., 2010; Weitz et al., 
2015).  Pharmacological therapy proved to be more effective in dysthymia patients, at 
least in short-term treatment.  In older adults, these two treatment modalities revealed no 
difference in treatment.  Special attention should always be paid to the benefits of 
individual assessment when prescribing treatment as usual ([TAU], Cuijpers et al., 2012).  
 There was a discrepancy in study outcomes with blinded and non-blinded control 
trials.  Cuijpers et al. (2015) discovered that in non-blinded trials PCT was superior in 
depression treatment and in blinded trials there was no significant difference between 
treatment with CBT or PCT.  The difference in the outcomes of these two forms of trials 
brought to the forefront the importance of awareness in trial procedures and outcomes.  
 Depression treatments that showed no difference in patient outcomes had several 
mechanisms of action.  Negative cognitive structure changed more rapidly with CBT and 
cognitive processing and depression severity changed more quickly with PCT.  Both 
treatment modalities impacted patient depression outcomes equally but utilized different 
mechanisms of action (Quilty et al. 2014). 
One of the most significant difference that CBT offers and PCT does not offer, is 
the long-acting effect on patient remission.  In multiple trials CBT presented with lower 
relapse rates and prolonged effects regardless of number of sessions.  Remission and 
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QOL were a major emphasis on depression management (Bockting et al., 2015; Cuijpers 
et al., 2013; Cuijpers et al., 2014;  Karyotaki et al., 2016;  Lam & Kennedy, 2015; Linde 
et al., 2015; Sinyor, Schaffer & Levitt, 2010).   
Assessment tools utilized in all categories of this integrative review were the 
DSM-IV and HDRS.  Additional tools utilized in the trials that showed no difference in 
treatment were: BDI, Inventory for Symptomology Score (IDSS), Psychological Distance 
Scaling Task (PDST), Research Diagnostic Criteria (RDC), Redundancy Card Sorting 
Task (RCST), Self-referent Encoding Task (SRET), and Well Being Index (WBI) and 
QOL.   
Combination.  Combination therapy with CBT and PCT, was the treatment 
modality with the third highest study numbers, 130 trials.  Since CBT was the most 
researched psychological therapy, this type of behavioral therapy was utilized in all 
categories of this integrative review.  Pharmacological therapy varied and presented no 
specific medication to utilize in this review.  
Most combination trials looked at CBT and PCT separately and then in 
combination.  Each of the 130 trials in this category researched CBT alone and PCT 
alone and assisted in identifying which therapy provided the best treatment outcomes.  
Cognitive behavioral therapy and PCT were then compared to combination therapy.  
Combination therapy was superior over monotherapy.  Even though monotherapy 
subjects showed improvement the level and speed of improvement increase with the 
combination of CBT and PCT.  Improvement in patient status impacted cost, 
effectiveness and patient well-being.  Often the depressed population is out of work or 
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produce poorer work outcomes.  Some may even be hospitalized.  All scenarios impact 
the depressed person’s ability to function in a productive manner and QOL.  One 
particular pattern continued to present in all the categories of this integrative review.  
Long-term effects, remission, and increased time between relapses, presented in all trials 
in which CBT was a factor (Cuijpers et al., 2013; Cuijpers et al., 2012; Cuijpers et al., 
2010; Hollon et al., 2014; IsHak et al., 2011; Wiles et al., 2013; Sinyor et al., 2010). 
The combination therapy trials utilized both therapies in different sequences. 
Some of the patterns initiated PCT first, and then added CBT.  Pharmacotherapy and 
CBT were combined at the same time, or PCT was discontinued, and BCT continued 
with sessions approximately every month.  These were some of the sequenced patterns 
that were utilized. However, PCT and CBT were used in combination for a significant 
time to gather the specific data needed to adequately evaluate treatment pattern results. 
All the articles analyzed in this integrative review utilized the DSM-IV and HDRS to 
measure depression, response, remission, recovery and QOL.  Evidence from the 
combination therapy study, revealed one trial response from combination therapy, five 
trials exhibited remission, one trial presented with recovery, and three trials revealed 
QOL impact.  
Additional tools were utilized to obtain further detailed data.  The additional 
universal depression measurement validation tools were: BDI, Berlin Quality of Life 
Profile (BQOLP), and Clinical Global Impression-Severity Scale (CGI-SS), 
Dysfunctional Attitude Scale (DAS), DMS-IV, MADRS, 36 Item Short Form Health 
Survey (SF-36), EuroQol EQ-5D Scale (Q-ES-Q/Q-LES-Q-SF), Quality of Life in 
28 
 
Depression Scale (QLDS), Social Adjustment Scale-Self-Report (SAS-SR), +Quality of 
Wellbeing (QWB), and World Health Organization Quality of Life Assessment 
Instrument (WHOQOL-100 & WHO-QOL-BREF). 
The trials evaluating combination research had high reliability based on the 
Melnyk levels of evidence pyramid (2011).  There were three level one studies, three level 
two studies, and one level three.  These studies contain 130 trials with 8116 subjects.  This 
category made particular reference to, CBT and PCT monotherapy effectiveness.  However, 
the overall research revealed that combination therapy was better than the monotherapy 
and impacted QOL, whereas the other categories had very little impact on QOL. (Cuijpers 
et al., 2013;Cuijpers et al., 2012; Cuijpers et al., 2010;  Hollon et al,, 2014; IsHak et al,, 
2011; Kohler et al., 2013; Wiles et al. , 2013; & Sinyor et al., 2010). 
Pharmacotherapy.  Pharmacotherapy had the fewest response therapy outcomes 
in this integrative review.  Pharmacotherapy offered a faster treatment response than 
CBT.  Kocsis et al. (2012) go as far as to make reference that first line monotherapy 
with PCT, is contradicted by the national guidelines set by NICE (2015).  Currently, 
NICE (2015) recommends sociological management and CBT as first line therapy for 
depression.  
Antidepressant medications have a broad spectrum of therapies; anti-anxiolytics 
to antipsychotics.  Pharmacotherapy options may appear to be a quick fix and easier to 
manage than some of the other therapies within the CBT family.  Medication can be 
obtained on sliding scale income fees at some clinics and pharmacies.  Some drug 
companies will offer free medication if finances are preventing the patient from obtaining 
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the drug.  Once PCT treatment begins an assessment of symptoms and medication 
adjustment takes place every three to four weeks.  Medication can be increased or titrated 
down, as the patient’s condition warrants.  This allows the patient some control over the 
treatment regimen.  There are times when this may impact the patient’s treatment 
response by giving the patient a sense of control. (Parker et al., 2013; Kocsis et al., 2009). 
No medication is without side effects.  Changes and titrations, in medications, 
may be made to help achieve the correct medication and dose.  Patients presenting with 
first-time depression generally remain on medication for one year after symptom 
remission.  Patients presenting with a second depression episode warrants two years on 
medication after symptom remission.  Patients presenting with a third episode of 
depression or never achieving remission will remain on medication for life (Alexopoulos 
et al., 2001).  
For continuity in metrics the same two depression assessment tools are 
represented in all the research articles. Some the articles have additional assessment tools 
but the two tools that were in all the studies were DSM-IV and HDRS.  The PCT 
category contained two trials, 20,645 subjects, and one trial provided data for symptom 
response with PCT, and in two trials the subjects reached remission.  Note, that each trial 
may have achieved more than one measurement of validity. 
Discussion 
During the data review of scholarly articles on CBT and PCT for adult depression, 
four key categories became apparent.  This integrative review began by looking only at 
the comparison between CBT alone and PCT alone.  However, it became apparent that 
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there were other options present in a large portion of research on this topic.  Taking this 
into account, an extensive data search and analysis was performed.  This integrative 
review expanded the original depression treatment option comparison to include: CBT 
alone, PCT alone, no difference in treatment with CBT verses PCT, and treatment with 
combination of CBT and PCT.  
From the literature utilized in this review, the largest number of research trials 
showed CBT demonstrated the best therapeutic patient outcomes, remission, and 
enduring effects for long term efficacy.  The second largest display of trials revealed no 
difference in treatment with CBT or PCT.  These therapies presented with response and 
remission of depression.  The third largest presentation of trials revealed that combination 
therapy with CBT and PCT presented the best treatment results.  The fourth and final 
category of depression treatment was PCT, which contained two trials.   
At the conclusion of the research for this integrative review an analysis of 
research presented a gap.  There did not appear to be any literature that categorized adult 
depression treatments into the four categories as seen in this integrative review.  Recent 
research literature was presenting evidence that specific patient populations may respond 
better to one therapy verse the other.  Personalized therapy is a therapy that is now 
becoming a topic of research.  There were multiple research articles in this integrative 
review that made reference to individualized medicine (Bockting et al., 2015; Cuijpers, et 
al., 2012; Cuijpers, et al., 2013; Driessen, et al., 2016; Hegerl et al., IsHak et al., 2011; 
2010; Karyotaki et al., 2016; Quilty et al., 2014; Roshanaei-Moghaddam et al., 2011; 
Sinyor et al., 2010; Weitz et al., 2015).  
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More research is needed to determine if patient demographics or characteristics 
play an important role in individual response to different depression treatment modalities. 
Exploration of individualized medicine would prevent the trial and error approach to 
treatment.  Individualized medicine could be cost effective and more therapeutic in 
assisting patients in symptom remission and QOL improvement.  This integrative review 
has limitations including limited studies, and unequal study numbers for each treatment 
modality, only one reviewer, and limited treatment modalities.  
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Table 1 
Inclusion and Exclusion Criteria 
Inclusion      Exclusion 
Publication from 2009-2016  Publication prior 2009 
Depression patients 
Age 18-65  
No comorbid conditions 
 Comorbid conditions 
Outside age range                                          
   
    
   
Cognitive behavioral therapy      Other forms of  
Pharmacotherapy       depression treatment 
US Journal in English      Foreign journals  
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Appendix A 
Literature Matrix 
Cognitive Behavioral Therapy Depression Treatment 
Focus of 
Article, 
Author/year 
Level of 
Evidence 
Elements and Core 
Concepts of 
CBT; Goals: 
Remission or 
Quality of Life 
Outcomes, 
Conclusions, 
And 
Recommendations 
Description of 10 
year follow up on 
recurrent 
depression with 
CBT, (Bockting et 
al., 2015) 
II  CBT stopped after 
depressive episode 
& this showed long 
term effects 
 DSM-IV criteria 
 HRSD,TIC-
P,SCID-I, DAS 
 Randomized 
control trial 
 172 patients 
 Remission 
 Personalized 
medical approach 
 CBT has long-term 
preventive effects 
on reoccurrences 
 At 10 years the 
group with CBT 
that had multiple 
depression 
episodes was still 
better than the 
group with PCT 
 Increased episodes 
of depression 
increased 
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 Long term effects 
with CBT 
 
resistance against 
the effects of PCT 
Description of  CBT 
on enduring 
effects superiority 
over PCT 
(Cuijpers et al., 
2013) 
I  9 studies with 506 
patients 
 HAMD 
 Definitions in 
article p.2 
 Remission 
 Enduring effects 
continue after 
treatment with 
CBT 
 No difference acute 
care CBT and 
pharm continuation 
on remission 
 CBT superior when 
compared to acute 
care CBT and 
acute PCT and 
stopped post 
discharge 
Description of CBT 
on depression 
remission, 
recovery, and 
improvement, 
(Cuijpers, 2014) 
I  92 studies, 6937 
patients 
 DBI, BDI-II, 
HAM-D 
 Remission 
 CBT superior in 
symptom treatment 
and Remission 
 Offers long term 
effects 
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Description of CBT 
in combination 
and monotherapy 
long term effects, 
(Karyotaki et al., 
2016)   
I  23 randomized 
control trials 
 2184 patients 
 Recovery > 26 
consecutive weeks 
without relapse 
 Depression rating 
scales by American 
Psychiatric  
Association (p.146) 
 In acute phase 
CBT is superior to 
combined therapy 
 In long term CBT 
is as effective as 
combination 
 Has long-term 
effects 
Description of CBT 
effectiveness in 
MDD, (Linde et 
al., 2015) 
I  Compared to PCT       
and placebo 
 CBT is effective 
 Less resource   
intensive 
 More eclectic 
rather than 
dogmatic 
 30 studies 
 5,159 patients 
 Remission 
 CBT of less 
resources may have 
similar effects as 
more intensive 
treatment 
 50% decrease on 
depression score 
 Depression 
measurement tools: 
HRSD, BDI-FS, 
MADRS 
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 Offers options for 
patients wishing to 
pursue non-
pharmalogical 
treatment 
 
 
 
Note: BDI-FS= Beck Depression Inventory Fast Screen, CBT= Cognitive Behavior 
Therapy, DAS= Dysfunctional Attitude Scale, DSM-IV criteria, HRSD= Hamilton 
Rating Scale for Depression, MADRS= Montgomery Asburg Depression Rating Scale, 
MDD= Major Depressive Disorder, PCT=Pharmacotherapy, TIC-P= Trimbo’s /IMTA 
Self Report Questionnaire for Costs Associated with Psychiatric Illness, SCID-I= 
Structural Clinical Interview for DMS-IV, DAS,  
Metrics: Patient participation=15,299, Trials=111, Remission=6, Recovery=1 
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Pharmacotherapy Depression Treatment 
Focus of 
Article, 
Author/year 
Level of 
Evidence 
Elements and Core 
Concepts of CBT; 
Goals: Remission or 
Quality of Life 
Outcomes, 
Conclusions, And 
Recommendations 
Description of PCT 
superiority to 
CBT in 12 week 
blind randomized 
study (Parker et 
al., 2013) 
 
II  .Randomized 
 . 29 participants 
 .HAM-D, HES 
 .Measured respond and 
remission 
 Low NNT shows 
superiority over CBT 
 18 participants 
received 
antidepressants 
 11 received CBT 
 At 4 weeks 
antidepressant group 
had significant 
improvement,  
Description of 
augmentation of 
CBT and PCT to 
nonresponse 
chronic 
depression, 
II  . The REVAMP trial 
 .Randomized trial with 
three phases 
 .808 patients 
 . HDRS, DSM-IV 
 .Response and 
remission 
 Compare PCT to 
pharm with long-
term and acute CBT 
and compared to 
pharm and short-term 
CBT 
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(Kocsis et al., 
2009) 
 Findings revealed no 
significant 
improvement with 
the addition of CBT 
to PCT 
Note: CBT=Cognitive Behavior Therapy, HAM-D= Hamilton Rating Scale for 
Depression, HES= Hamilton Exogenous Subscale, NNT=Numbers needed to treat,  
PCT= Pharmacotherapy 
Metrics: Patients=837, Trials=2, Remission=2 
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Combination Depression Treatment; Pharmacotherapy and Cognitive Behavioral 
Therapy 
Focus of 
Article, 
Author/year 
Level of 
Evidence 
Elements and Core 
Concepts of CBT; 
Goals: Remission or 
Quality of Life 
Outcomes, Conclusions, 
And Recommendations 
Description  of 
comparative therapy 
in depression, 
(Cuijpers et al., 
2013) 
 
I  Meta-analysis 
 20 studies (compare 
CBT to PCT show 
no difference in 
treatment) 
 (115 overall studies, 
show combination 
best) 
 HDRS, BDI 
 Response and 
remission 
 Study indicated no 
significant difference 
in treatment between 
these 2 type of 
treatment 
 But in Combined 
treatment is 
significantly more 
effective 
 Measures 2 of the 
groups looked at in this 
1 study 
Description of 
combination PCT 
and CBT, Separate, 
I  Systematic review 
 54 studies combined 
 4734 participants 
 29 studies comparing 
PCT and combined 
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and personalized 
depression treatment 
(Cuijpers et al., 
2012) 
 Combined therapy is 
best for depressed 
out patients and 
older people 
 20 characteristics 
were examined   
 Measure of 
remission  
 
 14 comparisons 
between CBT and 
combined 
 No significant 
difference between 
treatment with CBT or 
PCT 
 In outpatient combined 
therapy significantly 
more effective 
Description of 
comparative look at 
combination and 
PCT for adult 
depression, 
(Cuijpers et al., 
2010) 
I  Meta-analysis, 
randomized 
controlled trials 
 16 studies, 852 
patients 
 HAMD, BDI, 
 Response, 
Remission 
 No significant was 
found between CBT  
and PCT 
 413 patients CBT and 
pharm combination 
 439 patients 
combination CBT   and 
placebo 
 No findings to support 
that PCT was any more 
effective than CBT in 
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more sever baseline 
depression 
Description of 
combined CBT and 
pharm verses PCT 
alone (Hollon et al., 
2014) 
II  Randomized clinical 
trial 
 452 adult patients 
 3 University Clinics 
involved 
 HRSD, DMS-IV, LI 
 Remission 
 Combined Enhanced 
rate of recovery 
 Fewer dropouts 
 Fewer adverse events 
 Experienced less time 
in the MDD episode 
 CBT: 50 minute  
sessions Twice weekly 
for 2 weeks, then 
weekly after acute 
 Then at least monthly 
during continuation 
Description of 
combination, PCT, 
or CBT( & 
psychotherapies) on 
QOL with 
depression patients, 
(IsHak et al., 2011) 
I  Review 
 Screening scales SF-
36, WHOQOL-100, 
WHOQOL-BREF, 
EQ-5D, Q-ES-Q/Q-
LES-Q-SF, QLDS, 
QWB, BQOLP, 
 All treatments showed 
some improvement but 
most significant is 
combined therapy 
 Combined showed 
greater reduction in 
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CGI-SS, MADRS, 
SAS-SR, HRSD 
 36  studies 
 14,669 patients 
 7 studies 
psychotherapy alone 
(608 pts) 
 23 studies PCT 
alone  (12,225 pts) 
 7 studies combined 
therapy (1836 pts) 
 Remission & 
improved QOL 
symptoms  and 
improved QOL 
 Health focus is 
changing from life 
preserving to increased 
quality post 
intervention 
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Description of 
combination CBT 
and PCT 
effectiveness (Kohler 
et al., 2013) 
III  Controlled Trial 
 206 patients 
 Screening tools: 
BDI, HAMD, DAS, 
CGI-SS, DSM-IV, 
ICD-10 
 Response, recovery 
& remission 
 .Preformed under 
naturalistic conditions 
 Response to Treatment 
with PCT and CBT in- 
patient only (HAMD: 
19.86, BDI: 11.36) 
 Treatment with PCT 
and CBT & additional 
CBT post discharged 
from hospital (HAMD: 
22.21, BDI: 14.99) 
 Remission: Inpatient 
CBT   and PCT 
(HAMD: 51%, BDI: 
43.1%) 
 Remission: Inpatient 
CBT in addition to post 
discharge CBT and 
PCT (HAMD: 72%, 
BDI: 58.8%) 
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Description of 
combination in 
treatment resistant 
depression: CoBalt 
trial, (Wiles et al., 
2013) 
II  Randomized  
control trial 
 Screening tools: 
BDI, ICD-10,  
 469 patients 
 73 practices in UK 
 Response: 50% 
reduction in 
depressive 
symptoms within 6 
months (BDI) 
 Trial study on PCT, or 
PCT and CBT 
 Follow-up for 12 
months 
 Robust findings that 
CBT and PCT are 
effective at reducing 
depressive symptoms 
 At end of study 46% 
improved with PCT 
and CBT 
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 Response & 
improved QOL 
 22% improved with 
PCT alone 
Description of  
combination 
depression 
treatment, STAR*D, 
(Sinyor et al., 2010) 
II  Largest randomized 
trial done on CBT 
and PCT 
 6 years study 
 Cost US  $35 
million 
 Remission, QOL 
 2876 pts 
 4 levels; 1=PCT alone, 
2= augmentation to 
pharm, 3=equipoise-
stratified randomized 
(pt choice), 
4=randomized 2 PCT 
 Not a true test between 
PCT and CBT because 
pt was always on PCT 
even with CBT was 
introduced 
 CBT and PCT showed 
significant 
improvement than PCT 
alone  
 
Note: BDI= Beck Depression Inventory, BQOLP= Berlin Quality of Life Profile, CBT= 
Cognitive Behavioral Therapy, CGI-SS= Clinical Global Impression- Severity Scale, 
DAS=Dysfunctional Attitude Scale, DMS-IV= Diagnostic and Statistical Manual of 
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Mental Disorders 4th edition, HRSD= Hamilton Rate Scale for Depression, 
MADRS=Montgomery Asberg Depression Rating Scale, MDD= Major Depression 
Disorder, pts= Patients, PCT=Pharmacotherapy, SF-36= 36 Item Short Form Health 
Survey, Q-ES-Q/Q-LES-Q-SF=EuroQol EQ-5D Scale, QLDS= quality of Life in 
Depression Scale, QOL= Quality of Life, SAS-SR= Social Adjustment Scale-Self-
Report, QWB= Quality of Wellbeing, WHOQOL-100 & WHO-QOL-BREF= World 
Health Organization Quality of Life Assessment Instrument, UK=United Kingdom,  
Metrics: Patients=23,406, Trials=209, Remission=2, Response+remission=1, 
Remission+QOL=1, Response+recovery+remission=1, Response+QOL=1, 
Remission+QOL=1 
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No Significant difference between Two Depression Treatment Modalities; 
Pharmacotherapy or Cognitive Behavioral Therapy   
Focus of 
Article, 
Author/year 
Level of 
Evidence 
Elements and Core 
Concepts of 
CBT; Goals: 
Remission or 
Quality of Life 
Outcomes, 
Conclusions, And 
Recommendations 
Description of 
combination PCT 
and CBT, 
Separate, and 
personalized 
depression 
treatment (Cuijpers 
et al., 2012) 
I  Systematic 
review 
 54 studies 
combined 
 4734 participants 
 Combined 
therapy is best for 
depressed out 
patients and older 
people 
 20 characteristics 
were examined   
 Measure of 
remission  
 29 studies 
comparing PCT and 
combined 
 14 comparisons 
between CBT and 
combined 
 No significant 
difference between 
treatment with CBT 
or PCT 
 In outpatient 
combined therapy 
significantly more 
effective 
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 Description of PCT 
to CBT in  blinded 
study, (Cuijpers et 
al., 2015) 
1  35 randomized 
trials 
 3721patients 
 HAM-D-17 
 Remission 
 PCT superior to 
CBT in non-blinded 
study 
 No significant 
difference between 
CBT and PCT in 
blinded study-best  
indication 
Description  of 
comparative 
therapy in 
depression, 
(Cuijpers et al., 
2013) 
 
I  Meta-analysis 
 20 studies 
(compare CBT to 
pharm show no 
difference in 
treatment) 
 (115 overall 
studies, show 
combination best) 
 HDRS, BDI 
 Response and 
remission 
 Study indicated no 
significant 
difference in 
treatment between 
these 2 type of 
treatment 
 But in Combined 
treatment is 
significantly more 
effective 
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 Measures 2 of the 
groups looked at in 
this 1 study 
Description of 
comparative look 
at combination and 
PCT for adult 
depression, 
(Cuijpers et al., 
2010) 
I  Meta-analysis, 
randomized 
controlled trials 
 16 studies, 852 
patients 
 HAMD, BDI, 
 Response, 
Remission 
 No significant was 
found between CBT  
and PCT 
 413 patients CBT 
and PCT 
combination 
 439 patients 
combination CBT   
and placebo 
 No findings to 
support that PCT 
was any more 
effective than CBT 
in more sever 
baseline depression 
Description of 
comparative harms 
and benefits of 
I  An Evidence  
Report for 
 Moderate strength 
evidence 
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PCT, CBT, 
complementary 
and exercise 
therapy in 
depression, 
(Gartlehner et al., 
2016) 
Clinical Practice 
Guideline 
 Response and 
remission 
screening tools 
 20 RCT in 
22 .publications 
with 3000 
patients 
 Screening tools: 
HAM-D, BDI, 
HDRS, RDC  
 
 PCT and CBT led 
similar rates in 
response and 
remission 
 Guidelines from 
American College 
of Physicians 
 Similar response 
rates 8-16 weeks of 
treatment with CBT 
& PCT (CBT=44%, 
pharm 46%) 
 Similar Remission 
rates (41%CBT to 
48%PCT) 
 2 trials showed 
CBT had lower 
relapse rates 
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Description of 
comparison PCT 
and CBT including 
patient’s arm, 
(Hegerl et al., 
2010) 
II  368 patients 
 Randomized, 
placebo-
controlled, 
single-center  
 HDRS, IDSS, 
WHO-5, DSM-
IV, QOL 
 Response 
 Reduction in HDRS 
virtually identical; 
PCT 6.8, CBT 6.7 
 Scores show 
significant 
improvement in 
QOL 
 Patient Arm for 
choice decision did 
not impact outcome 
Description of 
comparison of 
PCT and CBT in 
atypical 
depression, 
(Henkel et al., 
2010) 
II  95 patients 
 HAMD 
 Post-hoc analysis 
 Response 
 Double blind and 
single blind study 
 10 week treatment 
period 
 Did not reveal any 
difference between 
CBT and PCT  
Description of 
combination  
/comparison of CBT 
and PCT in 
I  Meta-analysis, 
randomized 
control 
 21 studies 
 Similar effects with 
both treatments 
 Similar effects in 
groups with and 
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treatment of 
anxiety and 
depression, 
(Roshanaei-
Moghaddam et al., 
2011) 
 2027 patients: 
1095 PCT, 932 
CBT 
 HDRS 
 Response 
without placebo 
controls 
 
Description of 
cognitive structure 
and processing 
during CBT vs. 
PCT, (Quilty et al., 
2014) 
II  Randomized trial 
 104 patients 
 HAM-D, BDI-II, 
PDST, RCST, 
SRET 
 Symptom 
response 
 PCT showed earlier 
treatment response 
with lower 
depression severity 
by week 4 
 CBT showed earlier 
negative 
interpersonal 
content distance (in 
week 8) 
 Cognitive structure 
and processing are 
both impacted by 
CBT and PCT 
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Description of 
baseline 
depression 
outcomes between 
CBT and PCT 
(Weitz et al., 2015) 
I  Randomized 
clinical trials 
 DSM,HAM-D, 
BDI 
 16 trial 
 1700 out pts 
 Response and 
remission 
 794=CBT 
 906=PCT 
 CBT and PCT are 
equal in response 
and remission of 
baseline depression 
 
Note: BDI-II=Beck Depression Inventory, IDSS=Inventory for Symptomology Score, 
RCT= Random Control Trials, HDRS/HAM-D=Hamilton Depression Rating Scale, 
PCT=Pharmacotherapy, PDST=Psychological Distance Scaling Task, RDC= Research 
Diagnostic Criteria, RCST=Redundancy Card Sorting Task, SRET=Self-referent 
Encoding Task, WHO-5=Well-being Index, QOL=Quality of Life 
Metrics: Patients=11,867, Trials=116, Remission=1, Response=4,  
Response +remission 
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PRISMA 2009 Flow Diagram 
Appendix B 
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Additional records identified 
through other sources  
(n =20) 
Records after duplicates removed  
(n =76,204) 
Records screened 
(n= 76,204)    
  
(n =   ) 
Records excluded  
(n =76,077) 
Full-text articles assessed 
for eligibility  
(n =127) 
Full-text articles excluded, 
with reasons  
(n 104) 
Studies included in 
quantitative synthesis 
(meta-analysis)  
(n =23) 
Welch V, Petticrew M, Tugwell P, Moher D, O'Neill J, & Waters, E. 
(2012) PRISMA-Equity 2012 Extension: Reporting Guidelines for 
Systematic Reviews with a Focus on Health Equity. PLoS Med 9(10): 
e1001333. doi:10.1371/journal.pmed.1001333 
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Table of Evidence 
Figure 1 
Author/Year Meta C
T 
RC
T 
n= pts n = 
trial 
Res Rem Rec QOL Findings 
Bockting et al. 
(2015) 
  1 172 1  1   CBT 
Cuijpers et al. 
(2013) 
1    506 9  1   CBT 
Cuijpers et al. 
(2014) 
1   6937 92  1   CBT 
Karyotaki et al. 
(2016) 
1   2184 23   1 w/o 
relaps
e 
 CBT 
Linde et al. 
(2015) 
1   5159 30  1   CBT 
 4 0 1 14,958 155 0 4 1 0 CBT Totals  
Cuijpers et al. 
(2015) 
1    3721 35  1   0 Diff 
Cuijpers et al. 
(2013) 
1    20 1 1   0 Diff 
Cuijpers et al. 
(2010) 
1   852 16 1 1   0 Diff 
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Gartlehner et al. 
(2016) 
1   3000 20 1 1   0 Diff 
Hegerl et al. 
(2010) 
  1 368 1 1    0 Diff 
Henkel et al. 
(2010) 
  1 95 1 1    0 Diff 
Roshanaei-
Moghaddam et 
al. (2011) 
1   2027 21 1    0 Diff  
Quilty et al. 
(2014) 
  1 104 1 1    0 Diff 
Weitz et al. 
(2015) 
1   1700 16 1 1   0 Diff 
 6 0 3 11,867 131 8 5 0 0 0 Diff Total 
Cuijpers et al. 
(2010) 
1   852 16 1 1   Combine 
Cuijpers et al. 
(2013) 
1    20     Combine 
Cuijpers et al. 
(2012) 
1   4734 54  1   Combine 
Hollon et al. 
(2014) 
  1 425 1  1   Combine 
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IsHak et al. 
(2011) 
1   14669 36  1  1 Combine 
Kohler et al. 
(2013) 
 1  206 1   1 1  Combine 
Wiles et al. 
(2013) 
   1 469 1 1   1 Combine 
Sinyor et al. 
(2010) 
  1 2876 1  1  1 Combine 
 3 1 3 8116 130 1 5 1 3 Combine 
Total 
Parker et al. 
(2013) 
  1 29 1  1   PCT 
Kocsis et al. 
(2009) 
  1 20,616 1 1 1   PCT 
 0 0 2 20,645 2 1 2 0 0 PCT Total 
           
TOTALS 13 1 9 51,068 418 11 16 2 3  
 
Note: Meta= mate-analysis, CT=Control trial, RCT= Randomized control trial, Pts= 
patients, Res = Response, Rem = Remission, Rec =Recovery, QOL= Quality of life, 
CBT=Cognitive behavioral therapy, PCT= Pharmacotherapy, Combine= Combination, 0 
Diff= No difference 
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Figure 2 
IRB Email of Approval 
Good Evening Terri, 
 
Based on the federal regulations (45 CFR 46.102(f)), your study is not considered human subjects 
research, so an approval letter is not warranted. I met with the Department of Nursing on March 9, and 
they are aware of this aspect of the regulations and the possibility of their students receiving non-
human subjects research letters from the IRB.  
 
Best, 
 
G. Michele Baker, MA, CIP   
Administrative Chair of Institutional Research 
The Graduate School 
 
(434) 592-5530  
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